Upgrades:
Canadian Western Bank (TSE:CWB) was upgraded by research analysts at National Bank Financial from a “sector perform market weight” rating to an “outperform market weight” rating in a research report issued to clients and investors on Sunday.
A number of other brokerages have also weighed in on CWB.
National Bankshares upgraded Canadian Western Bank from a “sector perform”
rating to a “buy” rating and set a C$44.00 price objective on the stock in a
research report on Monday. TD Securities boosted their price objective on
Canadian Western Bank from C$43.00 to C$47.00 in a research report on Tuesday,
February 15th. Raymond James boosted their price objective on Canadian Western
Bank from C$41.00 to C$43.00 and gave the stock an “outperform” rating in a
research report on Monday, February 28th. CIBC lowered Canadian Western Bank
from an “outperform” rating to a “hold” rating and reduced their price
objective for the stock from C$45.00 to C$38.00 in a research report on Monday,
April 11th. Finally, Barclays reduced their price objective on Canadian Western
Bank from C$44.00 to C$38.00 and set an “equal weight” rating on the stock in a
research report on Wednesday, May 11th. Three investment analysts have rated
the stock with a hold rating and six have assigned a buy rating to the
company’s stock. Based on data from MarketBeat.com, the stock has a consensus
rating of “Buy” and an average price target of C$42.86. Read
more …
Essex Property Trust (NYSE:ESS) was upgraded by analysts at The Goldman Sachs Group from a "sell" rating to a "buy" rating in a report issued on Tuesday, The Fly reports. The firm presently has a $338.00 target price on the real estate investment trust's stock, down from their previous target price of $352.00. The Goldman Sachs Group's price objective would indicate a potential upside of 15.80% from the company's current price.
Several other research analysts have also recently issued
reports on ESS. TheStreet cut shares of Essex Property Trust from a
"b-" rating to a "c+" rating in a report on Friday. Truist
Financial cut their target price on shares of Essex Property Trust from $378.00
to $370.00 and set a "buy" rating for the company in a research note
on Monday, March 21st. Piper Sandler cut their target price on shares of Essex
Property Trust from $420.00 to $400.00 in a research note on Wednesday, May
4th. Morgan Stanley increased their target price on shares of Essex Property
Trust from $335.00 to $365.00 and gave the company an "equal weight"
rating in a research note on Friday, April 8th. Finally, StockNews.com started
coverage on shares of Essex Property Trust in a research note on Thursday,
March 31st. They set a "hold" rating for the company. Two research
analysts have rated the stock with a sell rating, seven have given a hold
rating and nine have assigned a buy rating to the stock. According to
MarketBeat, the company has a consensus rating of "Hold" and an
average target price of $359.00. Read
more …
Cardinal Health (NYSE:CAH) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating in a report issued on Wednesday, Briefing.com reports. The brokerage presently has a $68.00 price target on the stock, up from their prior price target of $55.00. Evercore ISI's target price would suggest a potential upside of 19.93% from the company's current price.
Several other analysts also recently commented on the stock.
Credit Suisse Group dropped their target price on shares of Cardinal Health from
$60.00 to $58.00 and set a "neutral" rating on the stock in a report
on Friday, February 4th. StockNews.com cut shares of Cardinal Health from a
"strong-buy" rating to a "buy" rating in a research note on
Friday, May 6th. TheStreet cut shares of Cardinal Health from a "c+"
rating to a "d+" rating in a research note on Thursday, May 5th.
Zacks Investment Research raised shares of Cardinal Health from a
"sell" rating to a "hold" rating and set a $55.00 price
target for the company in a research note on Monday, March 14th. Finally,
Morgan Stanley raised shares of Cardinal Health from an "equal
weight" rating to an "overweight" rating and set a $74.00 price
target for the company in a research note on Tuesday, April 12th. Two analysts
have rated the stock with a sell rating, four have issued a hold rating and
four have given a buy rating to the company. Based on data from MarketBeat,
Cardinal Health has a consensus rating of "Hold" and an average
target price of $59.90. Read
more …
Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by research analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating in a research note issued to investors on Wednesday, The Fly reports.
A number of other brokerages also recently commented on CNI.
StockNews.com assumed coverage on Canadian National Railway in a research
report on Thursday, March 31st. They issued a "hold" rating for the
company. Argus raised Canadian National Railway from a "hold" rating
to a "buy" rating and set a $145.00 price target for the company in a
research report on Thursday, February 17th. They noted that the move was a
valuation call. Desjardins reduced their price objective on Canadian National
Railway from C$173.00 to C$172.00 in a research note on Thursday, April 28th.
Scotiabank cut their price target on Canadian National Railway from C$174.00 to
C$172.00 in a research note on Wednesday, April 27th. Finally, Deutsche Bank
Aktiengesellschaft boosted their price objective on Canadian National Railway
from $137.00 to $142.00 and gave the company a "buy" rating in a
report on Thursday, January 27th. Seventeen equities research analysts have
rated the stock with a hold rating and eight have issued a buy rating to the
company's stock. Based on data from MarketBeat.com, Canadian National Railway
currently has an average rating of "Hold" and a consensus target
price of $147.76. Read
more …



















